BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 38473908)

  • 1. Liquid Biopsy: A Game Changer for Type 2 Diabetes.
    Gradisteanu Pircalabioru G; Musat M; Elian V; Iliescu C
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilising extracellular vesicles for early cancer diagnostics: benefits, challenges and recommendations for the future.
    Pink RC; Beaman EM; Samuel P; Brooks SA; Carter DRF
    Br J Cancer; 2022 Feb; 126(3):323-330. PubMed ID: 35013578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs.
    Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D
    Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research.
    Ramirez-Garrastacho M; Bajo-Santos C; Line A; Martens-Uzunova ES; de la Fuente JM; Moros M; Soekmadji C; Tasken KA; Llorente A
    Br J Cancer; 2022 Feb; 126(3):331-350. PubMed ID: 34811504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Value and Application of Liquid Biopsy in Tumor, Neurodegeneration, and Muscle Degenerative Diseases.
    Chen L; Yang J; Xu G; Wu Y
    Methods Mol Biol; 2023; 2695():317-335. PubMed ID: 37450129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles.
    Corvigno S; Johnson AM; Wong KK; Cho MS; Afshar-Kharghan V; Menter DG; Sood AK
    Mol Cancer Ther; 2022 Jul; 21(7):1067-1075. PubMed ID: 35545008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer.
    Romano C; Martorana F; Pennisi MS; Stella S; Massimino M; TirrĂ² E; Vitale SR; Di Gregorio S; Puma A; Tomarchio C; Manzella L
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders.
    Mithraprabhu S; Chen M; Savvidou I; Reale A; Spencer A
    Leukemia; 2021 Oct; 35(10):2771-2783. PubMed ID: 34262132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsy for brain tumors.
    Shankar GM; Balaj L; Stott SL; Nahed B; Carter BS
    Expert Rev Mol Diagn; 2017 Oct; 17(10):943-947. PubMed ID: 28875730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management.
    Cucchiara F; Scarpitta R; Crucitta S; Scatena C; Arici R; Naccarato AG; Fogli S; Danesi R; Del Re M
    Pharmacogenomics; 2022 Jan; 23(2):119-134. PubMed ID: 35006002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring.
    Batool SM; Yekula A; Khanna P; Hsia T; Gamblin AS; Ekanayake E; Escobedo AK; You DG; Castro CM; Im H; Kilic T; Garlin MA; Skog J; Dinulescu DM; Dudley J; Agrawal N; Cheng J; Abtin F; Aberle DR; Chia D; Elashoff D; Grognan T; Krysan K; Oh SS; Strom C; Tu M; Wei F; Xian RR; Skates SJ; Zhang DY; Trinh T; Watson M; Aft R; Rawal S; Agarwal A; Kesmodel SB; Yang C; Shen C; Hochberg FH; Wong DTW; Patel AA; Papadopoulos N; Bettegowda C; Cote RJ; Srivastava S; Lee H; Carter BS; Balaj L
    Cell Rep Med; 2023 Oct; 4(10):101198. PubMed ID: 37716353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis, Monitoring, and Prognosis of Liquid Biopsy in Cancer Immunotherapy.
    Kong W; Chen T; Li Y
    Methods Mol Biol; 2023; 2695():127-143. PubMed ID: 37450116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunities and challenges of circulating biomarkers in neuroblastoma.
    Trigg RM; Shaw JA; Turner SD
    Open Biol; 2019 May; 9(5):190056. PubMed ID: 31088252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application.
    Li M; Li L; Zheng J; Li Z; Li S; Wang K; Chen X
    Mol Cancer; 2023 Feb; 22(1):37. PubMed ID: 36810071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy for liver diseases.
    Mann J; Reeves HL; Feldstein AE
    Gut; 2018 Dec; 67(12):2204-2212. PubMed ID: 30177542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of liquid biopsies in gastrointestinal cancer.
    Wu C; Zhang J; Li H; Xu W; Zhang X
    Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsy in lung cancer.
    Li L; Jiang H; Zeng B; Wang X; Bao Y; Chen C; Ma L; Yuan J
    Clin Chim Acta; 2024 Feb; 554():117757. PubMed ID: 38184141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy for precision diagnostics and therapeutics.
    Anitha K; Posinasetty B; Naveen Kumari K; Chenchula S; Padmavathi R; Prakash S; Radhika C
    Clin Chim Acta; 2024 Feb; 554():117746. PubMed ID: 38151071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy.
    Trino S; Lamorte D; Caivano A; De Luca L; Sgambato A; Laurenzana I
    Leukemia; 2021 Mar; 35(3):661-678. PubMed ID: 33299143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy in ovarian cancer: advantages and limitations for prognosis and diagnosis.
    Karimi F; Azadbakht O; Veisi A; Sabaghan M; Owjfard M; Kharazinejad E; Dinarvand N
    Med Oncol; 2023 Aug; 40(9):265. PubMed ID: 37561363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.